HS patient registry and sample storage study
Part of Infections, Skin clinical trials.
This study enrolls people with hidradenitis suppurativa (HS) to better understand the condition over time and store optional health information and samples. Being in the registry may help researchers learn about patterns in HS and support future research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 10 or older
- Have a confirmed diagnosis of HS by a clinician experienced in diagnosing HS
- Be able to give informed consent (and have a guardian consent if needed)
- You (or your legal guardian) must agree and be willing to follow the study steps
- If you cannot consent or no guardian is available, you cannot join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study explores how people with hidradenitis suppurativa (HS) participate in research. You'll report your health regularly using a device, and the goal is to better understand patient experiences.
This study looks at the physical and biological (body-related) characteristics of hidradenitis suppurativa. It may help researchers understand the condition better and improve future care.
This study collects and stores skin samples and related health information from people seen in OSU Dermatology clinics. It helps researchers better understand skin conditions and may lead to new treatments in the future.
This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.
This study tracks how secukinumab (a new medication) works for hidradenitis suppurativa—a painful skin condition with recurring boils and abscesses—in real-world patient care in Italy. Researchers want to understand treatment patterns and outcomes to help improve care for this condition.
This study looks at how skin cells work in people with hidradenitis suppurativa (HS), a condition that causes painful lumps under the skin. It aims to understand the disease better, which might lead to improved treatments in the future.
Hear when a new Hidradenitis Suppurativa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.